Ovo Labs

Ovo Labs

Private
Munich, BavariaHealthcare & Life Scienceshttps://www.ovo-labs.com

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$5.32M

Company Overview

Ovo Labs is a biotechnology company that develops therapeutics to improve the quality of human eggs and increase the success rate of in-vitro fertilization (IVF). Founded in January 2025 as a spin-off from the Max Planck Institute, the company aims to address age-related fertility decline by developing treatments that reduce genetic errors in eggs, known as aneuploidy. Ovo Labs is advancing three therapeutic candidates through preclinical development which have the potential to significantly increase IVF success rates. The company has operations in London, UK, and Munich, Germany, with its product development taking place at the Life Science Factory in Munich. In April 2025, Ovo Labs announced it had raised £4 million in a seed funding round to advance its therapeutics toward clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Non-AI

Keywords

fertility therapeuticsIVF treatmentegg quality improvementage-related infertilityfemtechfertility techoocyte qualityaneuploidy reductionfertility clinicsassisted reproductive technologyARTwomen's healthpreclinical biotechreproductive health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ovo Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ovo Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025

Ovo Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Received the Max Planck startup Award of the Stifterverband for 2026.

  • Jan 16, 2026

    Presented at Fertility 2026, the UK's largest fertility conference.

Ovo Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ovo Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ovo Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich, Bavaria
Year Founded2025
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.